Deceuninck NV
LSE:0MEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Deceuninck NV
LSE:0MEL
|
BE |
|
U
|
Univar Solutions Inc
F:0UV
|
US |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
US |
|
Idorsia Ltd
SIX:IDIA
|
CH |
|
P
|
Pacific Industrial Co Ltd
TSE:7250
|
JP |
|
Vadilal Enterprises Ltd
BSE:519152
|
IN |
|
Jadar Resources Ltd
ASX:JDR
|
AU |
|
F
|
First Foundation Inc
NYSE:FFWM
|
US |
|
S
|
Sichuan Hongda Co Ltd
SSE:600331
|
CN |
|
D
|
Devsisters Corp
KOSDAQ:194480
|
KR |
Wall Street
Price Targets
0MEL Price Targets Summary
Deceuninck NV
According to Wall Street analysts, the average 1-year price target for
0MEL
is 2.923 EUR
with a low forecast of 2.196 EUR and a high forecast of 4.046 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0MEL's stock price target?
Price Target
2.923
EUR
According to Wall Street analysts, the average 1-year price target for
0MEL
is 2.923 EUR
with a low forecast of 2.196 EUR and a high forecast of 4.046 EUR.
What is Deceuninck NV's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Deceuninck NV's revenue is
3%.
The projected
CAGR
for the next 4 years is
3%.
What is Deceuninck NV's Operating Income forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Deceuninck NV's operating income is
8%.
The projected
CAGR
for the next 4 years is
8%.
What is Deceuninck NV's Net Income forecast?
Projected CAGR
45%
For the last 13 years the
compound annual growth rate for
Deceuninck NV's net income is
6%.
The projected
CAGR
for the next 3 years is
45%.
